Significant improvement has been made since last year to enhance the safety of imported products, according to a new report released by the interagency working group on import safety.
Significant improvement has been made since last year to enhance the safety of imported products, according to a new report released by the interagency working group on import safety. Entitled the “Import Safety-Action Plan Update,” the report outlines steps taken by the federal government, private sector, and international partners to bolster import safety over the last eight months.
President Bush established an interagency working group on import safety in July 2007 and appointed Secretary Mike Leavitt as chairperson. The President charged the working group with conducting a comprehensive, government-wide review to identify actions and appropriate steps to promote the safety of imported products. In November 2007, the working group completed the “Action Plan for Import Safety,” a national strategy based on the principles of prevention, intervention, and response. It contains 14 broad recommendations and 50 specific short- and long-term action steps to better protect consumers and enhance the safety of the increasing volume of imports entering the United States.
According to the report, since November 2007, there have been strong enforcement actions, signed agreements with key trading partners, bilateral and multilateral discussions, critical information shared on safety and best practices, and a process begun to improve safety practices both inside and outside of government.
The accomplishments include:
Administration officials will continue to work with Congress to seek enactment of the recommendations from the November 2007 action plan requiring legislation.
Information on efforts to improve import safety and the report are available at www.importsafety.gov.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.